Alliant Specialty Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-12-2024
- Paid Up Capital ₹ 0.25 M
as on 09-12-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Profit 1054.59%
(FY 2020)
- Ebitda 1484.39%
(FY 2020)
- Net Worth 185.32%
(FY 2020)
- Total Assets 4554.50%
(FY 2020)
About Alliant Specialty Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.25 M, as per Ministry of Corporate Affairs (MCA) records.
Madhusudan Sarda, Narendra Karnavat, Pramod Hogale, and One other member serve as directors at the Company.
- CIN/LLPIN
U24304MH2018PTC420163
- Company No.
176446
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 May 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Alliant Specialty Chemicals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arpit Jhawar  | Director | 27-Apr-2021 | Current |
| Madhusudan Sarda | Director | 15-Mar-2023 | Current |
| Narendra Karnavat | Director | 09-Aug-2021 | Current |
| Pramod Hogale | Director | 17-Mar-2020 | Current |
Financial Performance and Corporate Structure Insights of Alliant Specialty Chemicals.
Alliant Specialty Chemicals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 1054.59% increase in profit. The company's net worth Soared by an impressive increase of 185.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alliant Specialty Chemicals?
In 2020, Alliant Specialty Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Everbrite Jewellery & Diamonds Private LimitedActive 4 years 3 monthsNarendra Karnavat is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Alliant Specialty Chemicals?
Unlock and access historical data on people associated with Alliant Specialty Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alliant Specialty Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alliant Specialty Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
